Schoenen, Stefanie
Heussen, Nicole
Verbeeck, Johan
Hilgers, Ralf-Dieter
Funding for this research was provided by:
Horizon 2020 (964908)
RWTH Aachen University
Article History
Received: 8 August 2023
Accepted: 6 September 2024
First Online: 30 September 2024
Declarations
:
: The EPISTOP trial registered in ClinicalTrials.gov under number NCT02098759 was approved by the Bioethics Commitee at the Children’s Memorial Health Institute (IPCZD) in Warsaw, Poland (66/KBE/2013) and all additional relevant national/local authorities, conducted in accordance with the Declaration of Helsinki, and all patients or their legal surrogates gave informed consent. Additional details on approvals and the informed consent procedure are available in the primary trial publication [].
: Not applicable.
: The authors declare no competing interests.